![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Laboratory of Nutrition Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School of Kyushu University, Fukuoka 812-8581, Japan;
* Central Research Institute, ITO EN, Ltd., Shizuoka 421-0516, Japan; and
Department of Environmental and Symbiotic Sciences, Faculty of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto 862-8502, Japan
1To whom correspondence should be addressed. E-mail: iikeda{at}agr.kyushu-u.ac.jp.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: catechins postprandial hypertriacylglycerolemia pancreatic lipase rats tea
Tea catechins consist mainly of 4 derivatives; ()-epicatechin (EC),2 ()-epigallocatechin (EGC), ()-epicatechin gallate (ECG), and ()-epigallocatechin gallate (EGCG) (Fig. 1). These catechins, which are contained in green tea, oolong tea, and black tea, have been shown to have hypocholesterolemic, antiatherogenic, antiobesity, antioxidative, and anticarcinogenic activities (110). We previously showed that tea catechins inhibit intestinal absorption of cholesterol in rats (11,12). It also has been reported that tea catechins prevent LDL oxidation (1315) and suppress atheroma formation in apoE knockout mice (5). These observations suggest that tea catechins are effective in preventing coronary heart disease. Because postprandial hypertriacylglycerolemia is a risk factor for coronary heart disease (16), its suppression by food components may effectively prevent the disease. Juhel et al. (17) showed that a green tea extract inhibited gastric and pancreatic lipases in vitro. Although the results suggest that a green tea extract slows or inhibits fat absorption in the intestine and suppresses postprandial hypertriacylglycerolemia, the effect has never been experimentally tested. Tea catechins are thought to be responsible for the lipase inhibitor in green tea extract. However, Han et al. (18) reported that tea saponins, not catechins, inhibited pancreatic lipase activity in vitro. In this study, the effect of tea catechins on postprandial hypertriacylglycerolemia was examined in rats, and the underlying mechanism was clarified in vitro and in vivo. We used rats as a model of postprandial hypertriacylglycerolemia, because the processes of digestion and absorption of dietary triacylglycerols are similar in rats and humans.
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Lymphatic recovery of 14C-trioleoylglycerol in rats cannulated in the thoracic duct. Nine-wk-old male Sprague Dawley rats cannulated in the thoracic duct were given i.g. 3 mL of a test emulsion containing 14C-trioleoylglycerol with or without catechins. After administration, lymph was collected for 24 h. The test emulsion (3 mL) contained 200 mg sodium taurocholate (Nacalai tesque), 50 mg fatty-acid-free bovine serum albumin fraction V (Bayer), 200 mg trioleoylglycerol (Sigma), and 37 kBq 14C-trioleoylglycerol in deionized water. When tea catechins and heat-treated tea catechins were administered, these catechins were added to the emulsion at 100 mg in 3 mL test emulsion, respectively. Operations and maintenance of rats and all other procedures were performed as described previously (22,23).
All rat studies were carried out under the guidelines for animal experiments of the Faculty of Agriculture, Graduate School Kyushu University and Central Research Institute, ITO EN, and Law 105 and Notification 6 of the government of Japan.
Micellar solubility of hydrolysis products of triacylglycerol in vitro. A micellar solution containing 1 mmol/L oleic acid (Sigma), 0.5 mmol/L 1-monooleoylglycerol (Sigma), 6.6 mmol/L sodium taurocholate, 0.6 mmol/L egg phosphatidylcholine (Sigma), and 132 mmol/L sodium chloride in 15 mmol/L sodium phosphate buffer (pH 6.8) was prepared by sonication and was kept at 37°C for 24 h for stabilization of the micelles. A solution of tea catechins or heat-treated tea catechins was added to the micelles (final concentration, 2 g/L micelles) and incubated for 1 h at 37°C. The micellar solution was passed through a 0.2-µm syringe filter (25 mm, GDD/X; Whatman). After lipid extraction from the filtrate, the concentration of total fatty acids was measured by GLC (24).
Activity of pancreatic lipase in vitro. The activity of pancreatic lipase was measured according to the method of Han et al. (18). An emulsion (9 mL) containing 80 mg trioleoylglycerol, 10 mg phosphatidylcholine, and 5 mg sodium taurocholate in 0.1 mol/L N-tris(hydroxymethyl)methyl-2-aminoethane sulfonic acid (TES) buffer (pH 7.0) containing 0.1 mol/L sodium chloride was prepared by sonication and kept at 37°C. A total of 100 µL of the emulsion was incubated with 5 U of porcine pancreatic lipase (Sigma) solubilized in 0.1 mol/L TES buffer containing 0.1 mol/L sodium chloride and various amounts of catechin solution (100 µL) at 37°C for 30 min. Released fatty acids were extracted with chloroform: heptane: methanol (49:49:2, v:v:v) and colorimetrically measured.
Statistical analysis. Data are expressed as means ± SEM. Statistical analysis of data were performed by two-way ANOVA or two-way repeated-measure ANOVA followed by the Tukey-Kramer test to identify differences among groups. Differences were considered significant at P < 0.05.
| RESULTS |
|---|
|
|
|---|
|
|
Activity of pancreatic lipase in vitro. The activity of pancreatic lipase was dose-dependently inhibited by the addition of tea catechins and heat-treated tea catechins (Fig. 4). There was no difference between the 2 catechin preparations.
|
|
| DISCUSSION |
|---|
|
|
|---|
In the study of suppression of postprandial hypertriacylglycerolemia (Fig. 2), catechins were administered at a concentration of 30 mg/g trioleoylglycerol. If we assume that one human meal contains 1530 g of fats, 450900 mg of catechins may be effective doses to inhibit postprandial hypertriacylglycerolemia in humans. Green tea beverages in Japan contain 250540 mg of heat-treated tea catechins per serving. Therefore, ingestion of a sufficient amount of catechins is possible. In a preliminary human study, we observed that postprandial hypertriacylglycerolemia in normal subjects was suppressed by the administration of a tea beverage containing about 700 mg/d of heat-treated catechins (unpublished results).
In our previous study, the effect of tea catechins rich in EGCG and ECG on lymphatic transport of fatty acids after intragastric administration of coconut oil or palm olein was examined in rats cannulated in the thoracic duct (11). When coconut oil was given, tea catechins delayed lymphatic recovery of fatty acids and the result was consistent with the observation in this study. When palm olein was given, there was no delayed lymphatic recovery, but total recovery for 24 h of fatty acids was lower by the administration of tea catechins. Therefore, the effect of tea catechins on fat absorption was equivocal in our previous work (11). In that study, lymphatic recovery of fatty acids was analyzed by GLC. Because endogenous fatty acids were contained in lymph fluids, quantitative estimation of absorbed fatty acids was impossible. In the present study, because lymphatic recovery of fatty acids was quantified using radiolabeled trioleoylglycerol, we think that precise information on the effect of tea catechins on fat absorption was obtained.
Han et al. (25) showed that tea saponin affected pancreatic lipase activity in vitro. However, they did not report the data, indicating that tea catechins did not inhibit the activity of pancreatic lipase. Although we followed their method to measure the inhibitory effect of tea catechins on pancreatic lipase activity, both tea catechins and heat-treated tea catechins dose-dependently inhibited pancreatic lipase activity (Figs. 4 and 5). Causes of the discrepancy are not clearly explained at present. It is also not evident if tea catechins and heat-treated tea catechins inhibit pancreatic lipase activity in vivo. However, because our study simultaneously showed the suppression of postprandial hypertriacylglycerolemia and delayed recovery of triacylglycerol in lymph by these catechin preparations, it is possible that tea catechins and heat-treated tea catechins inhibit pancreatic lipase activity.
Both tea catechins and heat-treated tea catechins contain unidentified components other than catechins (Table 1), likely polymerized or degradated catechins. It is possible that unknown components in catechin preparations also influence the activity of pancreatic lipase. In the present study, major components of heat-treated tea catechins GCG and CG more effectively inhibited the lipase activity than those of tea catechins EGCG and ECG (Fig. 5). Although these results suggest that heat-treated tea catechins that are rich in GCG and CG may more effectively inhibit pancreatic lipase than tea catechins that are rich in EGCG and ECG, different inhibitory effects on the lipase activity were not observed between tea catechins and heat-treated tea catechins (Fig. 4). We also showed that inhibitory effects by tea catechins and heat-treated tea catechins on postprandial hypertriacylglycerolemia and on lymphatic absorption of triacylglycerol were comparable (Figs. 2and 3). These results suggest that unidentified components contained in the preparations of tea catechins and heat-treated tea catechins may partly contribute to the inhibition of pancreatic lipase.
The activation of lipoprotein lipase may be another important determinant of postprandial triacylglycerol concentration in serum. However, because studies have never been conducted on this point, more studies on the effect of tea catechins on the activity of lipoprotein lipase are required.
Our previous study showed that tea catechins and heat-treated tea catechins precipitated cholesterol from bile-salt micellar solutions and inhibited cholesterol absorption in rats (12). In the present study, the addition of these tea catechins to a bile-salt micellar solution containing the hydrolysis products of triacylglycerols, fatty acids, and monooleoylglycerol did not affect the total fatty acid content in the micelles. The results show that the catechin preparations do not exclude oleic acid and monooleoylglycerol from a bile-salt micellar solution, suggesting that catechin preparations do not suppress triacylglycerol absorption by inhibiting micellar solubility of hydrolysis products of triacylglycerols.
Murase et al. (6) showed that long-term feeding of tea catechins, the major component of which was EGCG, reduced the deposition of visceral fat in mice fed a high-fat diet. They ascribed the reduced deposition of visceral fat to enhanced ß-oxidation in the liver. We suggest that the suppression of postprandial hypertriacylglycerolemia may be another reason for the antiobesity activity of tea catechins. Han et al. (25,26) have pointed out that slower absorption of dietary fat decreases the deposition of visceral fat. After a meal, the increase in blood glucose stimulates the secretion of insulin. Insulin activates peripheral lipoprotein lipase and then hydrolysis of chylomicron triacylglycerols is stimulated. Formed FFAs are mainly incorporated into adipose tissue and deposited as triacylglycerols. If the concentration of chylomicron triacylglycerols is higher, it is possible that the deposition of fatty acids hydrolyzed from triacylglycerols can be higher in adipose tissues. Therefore the suppression of postprandial hypertriacylglycerolemia by tea catechins may be a cause of the reduction of fat deposition.
In conclusion, our study suggests that both green tea catechins and heat-treated tea catechins suppress postprandial hypertriacylglycerolemia, a risk factor for the development of coronary heart disease. Our results, together with previous observations, such as cholesterol-lowering activity (27,28) and prevention of LDL oxidation in vitro (13) and in human studies (14,15), strongly suggest that the ingestion of tea catechins may prevent coronary heart disease. Our results also suggest that heat-treated tea catechins contained in canned and bottled tea beverages widely consumed in Asian countries have the same effect on postprandial hypertriacylglycerolemia as tea catechins.
| FOOTNOTES |
|---|
Manuscript received 4 July 2004. Initial review completed 22 July 2004. Revision accepted 21 October 2004.
| LITERATURE CITED |
|---|
|
|
|---|
1. Muramatsu, K., Fukuyo, M. & Hara, Y. (1986) Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 32:613-622.
2. Chisaka, T., Matsuda, H., Kubomura, Y., Mochizuki, M., Yamahara, J. & Fujimura, H. (1988) The effect of crude drugs on experimental hypercholesteremia: mode of action of ()-epigallocatechin gallate in tea leaves. Chem. Pharm. Bull. 36:227-233.
3. Yang, T.T.C. & Koo, M.W.L. (2000) Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci. 66:411-423.[Medline]
4. Chan, P. T., Fong, W. P., Cheung, Y. L., Huang, Y., Ho, W.K.K. & Chen, Z.-Y. (1999) Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J. Nutr. 129:1094-1101.
5. Miura, Y., Chiba, T., Tomita, I., Koizumi, H., Miura, S., Umegaki, K., Hara, Y., Ikeda, M. & Tomita, T. (2001) Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr. 131:27-32.
6. Murase, T., Nagasawa, A., Suzuki, J., Hase, T. & Tokimitsu, I. (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int. J. Obes. 26:1459-1464.
7. Okuda, T., Kimura, Y., Yoshida, T., Hatano, T., Okuda, H. & Arichi, S. (1983) Studies on the activities of tannins and related compounds from medicinal plants and drugs. I. Inhibitory effects on lipid peroxidation in mitochondria and microsomes of liver. Chem. Pharm. Bull. 31:1625-1631.
8. Yoshino, K., Tomita, I., Sano, M., Oguni, I., Hara, Y. & Nakano, M. (1994) Effects of long term dietary supplement of tea polyphenols on lipid peroxide levels in rats. Age 17:79-85.
9. Kada, T., Kaneko, K., Matsuzaki, S., Matsuzaki, T. & Hara, Y. (1985) Detection and chemical identification of natural bioantimutagens. A case of the green tea factor. Mutat. Res. 150:127-132.[Medline]
10. Fujiki, H., Suganuma, M., Okabe, S., Sueoka, N., Komori, A., Sueoka, E., Kozu, T., Tada, Y. & Suga, K., et al (1998) Cancer inhibition by green tea. Mutat. Res. 402:307-310.[Medline]
11. Ikeda, I., Imasato, Y., Sasaki, E., Nakayama, M., Nagao, H., Takeo, T., Yayabe, F. & Sugano, M. (1992) Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim. Biophys. Acta 1127:141-146.[Medline]
12. Ikeda, I., Kobayashi, M., Hamada, T., Tsuda, T., Goto, H., Imaizumi, K., Nozawa, A., Sugimoto, A. & Kakuda, T. (2003) Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J. Agric. Food Chem. 51:7303-7307.[Medline]
13. Miura, S., Watanabe, J., Tomita, T., Sano, M. & Tomita, I. (1994) The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein. Biol. Pharm. Bull. 17:1567-1572.[Medline]
14. Miura, Y., Chiba, T., Miura, S., Tomita, I., Umegaki, K., Ikeda, M. & Tomita, T. (2000) Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. J. Nutr. Biochem. 11:216-222.[Medline]
15. Nakagawa, K., Ninomiya, M., Okubo, T., Aoi, N., Juneja, L. R., Kim, M., Yamanaka, K. & Miyazawa, T. (1999) Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans. J. Agric. Food Chem. 47:3967-3973.[Medline]
16. Cohn, J. S. (1998) Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins. Can. J. Cardiol. 14(Suppl. B):18B-27B.
17. Juhel, C., Armand, M., Pafumi, Y., Rosier, C., Vandermander, J. & Lairon, D. (2000) Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J. Nutr. Biochem. 11:45-51.[Medline]
18. Han, L.-K., Takuma, T., Li, J., Kimura, Y. & Okuda, H. (1999) Anti-obesity action of oolong tea. Int. J. Obes. 23:98-105.
19. Chen, Z.-Y., Xhu, Q. Y., Tsang, D. & Huang, Y. (2001) Degradation of green tea catechins in tea drinks. J. Agric. Food Chem. 49:477-482.[Medline]
20. Seto, R., Nakamura, H., Nanjo, F. & Hara, Y. (1997) Preparation of epimers of tea catechins by heat treatment. Biosci. Biotechnol. Biochem. 61:1434-1439.
21. Kido, Y., Hiramoto, S., Murao, M., Horio, Y., Miyazaki, T., Kodama, T. & Nakabou, Y. (2003)
-Polylysine inhibits pancreatic lipase activity and suppresses postprandial hypertriacylglyceridemia in rats. J. Nutr. 133:1887-1891.
22. Ikeda, I., Tanaka, K., Sugano, M., Vahouny, G. V. & Gallo, L. L. (1988) Inhibition of cholesterol absorption in rats by plant sterols. J. Lipid Res. 29:1573-1582.[Abstract]
23. Ikeda, I., Nakagiri, H., Sugano, M., Ohara, S., Hamada, T., Nonaka, M. & Imaizumi, K. (2001) Mechanisms of phytosterolemia in SHRSP and WKY rats. Metabolism 50:1361-1368.[Medline]
24. Ikeda, I., Imasato, Y., Nagao, H., Sasaki, E., Sugano, M., Imaizumi, K. & Yazawa, K. (1993) Lymphatic transport of eicosapentaenoic and docosahexaenoic acids as triglyceride, ethyl ester and free acid, and their effect on cholesterol transport in rats. Life Sci. 52:1371-1379.[Medline]
25. Han, L.-K., Kimura, Y., Kawashima, M., Takaku, T., Taniyama, T., Hayashi, T., Zheng, Y.-N. & Okuda, H. (2001) Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int. J. Obes. 25:1459-1464.
26. Han, L.-K., Kimura, Y. & Okuda, H. (1999) Reduction in fat storage during, chitin, chitosan treatment in mice fed a high-fat diet. Int. J. Obes. 23:174-179.
27. Nozawa, A., Sugimoto, A., Nagata, K., Kakuda, T. & Horiguchi, T. (2002) The effects of a beverage containing tea catechins on serum cholesterol level. J. Nutr. Food 5:1-9 (in Japanese).
28. Kajimoto, O., Kjimoto, Y., Yabune, M., Nozawa, A., Nagata, K. & Kakuda, T. (2003) Tea catechins reduce serum cholesterol levels in mild and borderline hypercholesterolemia patients. J. Clin. Biochem. Nutr. 33:101-111.
This article has been cited by other articles:
![]() |
C. Auger, W. Mullen, Y. Hara, and A. Crozier Bioavailability of Polyphenon E Flavan-3-ols in Humans with an Ileostomy J. Nutr., August 1, 2008; 138(8): 1535S - 1542S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuzuki, Y. Kawakami, R. Abe, K. Nakagawa, K. Koba, J. Imamura, T. Iwata, I. Ikeda, and T. Miyazawa Conjugated Linolenic Acid Is Slowly Absorbed in Rat Intestine, but Quickly Converted to Conjugated Linoleic Acid J. Nutr., August 1, 2006; 136(8): 2153 - 2159. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||